Animal Core
动物核心
基本信息
- 批准号:8392592
- 负责人:
- 金额:$ 31.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-05-01 至 2017-04-30
- 项目状态:已结题
- 来源:
- 关键词:A MouseAccreditationAmendmentAnesthesia proceduresAnimal HousingAnimal TechniciansAnimal Welfare ActAnimalsAutopsyBiologicalBiological AssayBiological ProductsBiomedical ResearchBlood Chemical AnalysisBlood specimenBreedingCanis familiarisCaringCell LineCenter for Translational Science ActivitiesChildhoodClipCommitCommunitiesContainmentDNADataDevelopmentDiagnosticDiagnostic radiologic examinationDiseaseEarEnsureEvaluationExonsExperimental ModelsFacultyFundingGenerationsGenotypeHealthHealthcareHematologyHemophilia AHemorrhageHemostatic AgentsHemostatic functionHistopathologyHousingHuman ResourcesIndividualInjuryInternationalInterventionIntravenous infusion proceduresInvestigationKnock-outLaboratoriesLaboratory Animal MedicineLaboratory AnimalsLawsMaintenanceMarketingMesenteric ArteriesMicrobiologyModelingMolecularMusOperative Surgical ProceduresParasitologyParticipantPersonsPlasmaPlasmidsPolicePoliciesPostoperative PeriodPreclinical TestingPreventive MedicineProceduresPublicationsQuarantineRNARecordsResearchResourcesRodentSanitationSentinelSerologic testsServicesSpecimenStagingStandardizationTailThrombosisTimeTissue HarvestingTissuesTransgenic MiceUnited States Public Health ServiceUniversitiesVariantVendoranimal careanimal facilityartery occlusionassay developmentbasecomparativecyclophilin Dfollow-upguide for the care and use of laboratory animalsimmunogenicityinhibitor/antagonistmeetingsminimally invasivemouse modelnovelpre-clinicalprogramsresearch clinical testingresearch studytoolvon Willebrand Disease
项目摘要
Introduction
Mouse models are routinely used in biomedical research as preclinical tools of investigation. For example, in the development of novel agents for the treatment of persons with hemophilia A, the hemophilia A mouse model is routinely used to demonstrate treatment proof of concept as well as investigate comparative
immunogenicity. The hemophilia A mouse models, one generated by knockout of exon 16 and another by knockout of exon 17, were first developed in the laboratory of Dr. Haig Kazazian (1, 2). To date, there have been over 400 publications utilizing these animals and several biological agents in commercial development or currently marketed have been subjected to pre-clinical testing in these models. Although there are canine
hemophilia models available to the biomedical research community, their numbers are extremely limited and typically these animals are only utilized for late stage preclinical testing. Therefore, the currently proposed projects only involve mouse studies. No support for large animals is requested at this time.
Resources available to the Emory TRC-THD participants for the care and maintenance of mice in the proposed research are substantial. Emory University has animal facilities located in 8 buildings, on or near the main campus, including the Pediatric ECC building, where animals for this proposal will be housed and the experiments will be conducted. Additional breeding colonies are maintained in the Whitehead Building, also on
the main campus. These two buildings have over 60 animal housing rooms, procedure rooms, modern animal surgeries, radiographic resources, diagnostic laboratories, and bio-containment facilities. There is an Animal Care Unit that ensures daily maintenance and routine animal care, including provision of proper housing.
Sanitation and nourishment are provided based on the University's policy. This proposal will benefit from a specialized core rodent breeding services staffed by nine managers/supervisors and 42 technicians. In addition, a Veterinary Services Unit provides for the entire animal health care program. The components of this program include vendor surveillance, quarantine and isolation, preventive medicine, daily observation, treatment and intervention for injury or illness, health evaluations of sentinel animals, necropsy, histopathology, parasitology, microbiology, serology, hematology and blood chemistries. Additionally, the staff of the Laboratory Animal Medicine Unit can provide assistance with animal anesthesia, surgery, radiography and
post-operative care. It is staffed by two faculty DVMs, two resident DVMs, and six veterinary technicians.
Finally, Emory University is committed to providing a quality program of animal care in compliance with state and federal laws and the standards and polices of the Public Health Service. The standards of the program meet or exceed the federal Animal Welfare Act PL 89-544 (1966) and subsequent amendments and the documents entitled "Guide for the Care and Use of Laboratory Animals" and "Public Health Service Policy on
Humane Care and Use of Laboratory Animals". Emory University has been continuously accredited campus wide by the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC) since 1992.
介绍
小鼠模型通常在生物医学研究中用作临床前研究工具。例如,在开发用于治疗血友病患者的新型药物时,血友病A小鼠模型通常用于证明概念的治疗证明,并研究了比较
免疫原性。 Haig Kazazian博士(1,2)的实验室首次开发了由外显子16敲除外显子16产生的小鼠模型,另一种是由外显子17的敲除产生的。迄今为止,已经有400多个出版物利用这些动物,而在这些模型中,已经进行了商业开发或目前销售的几种生物制剂。虽然有犬
生物医学研究界可用的血友病模型非常有限,通常这些动物仅用于后期临床前测试。因此,当前提出的项目仅涉及小鼠研究。目前不要求大型动物的支持。
在拟议的研究中,埃默里(Emory)TRC-THD参与者可用于保养和维护小鼠的资源是大量的。埃默里大学(Emory University)在主要校园内或附近的8座建筑物中设有动物设施,包括儿科ECC大楼,该建筑将安置该提案的动物,并将进行实验。怀特海建筑物也维持了其他繁殖菌落
主校园。这两座建筑物设有60多个动物住房室,手术室,现代动物手术,射线照相资源,诊断实验室和生物接触设施。有一个动物护理部门可确保每日维护和常规动物护理,包括提供适当的住房。
根据大学的政策提供了卫生和营养。该建议将受益于由九名经理/主管和42位技术人员组成的专业核心啮齿动物育种服务。此外,兽医服务部门为整个动物卫生保健计划提供了。该计划的组成部分包括供应商的监视,隔离和隔离,预防医学,损伤或疾病的日常观察,治疗和干预,前哨动物的健康评估,死灵病,组织病理学,寄生虫学,微生物学,血清学,血液学,血液学和血液化学。此外,实验室动物医学部门的工作人员可以为动物麻醉,手术,射线照相和
术后护理。它由两名DVMS,两个居民DVM和六位兽医技术人员组成。
最后,埃默里大学(Emory University)致力于根据州和联邦法律以及公共卫生服务的标准和政策提供高质量的动物护理计划。该计划的标准符合或超过《联邦动物福利法》 PL 89-544(1966)以及随后的修正案以及题为“实验室动物的护理和使用指南”和“公共卫生服务政策的指南”
自1992年以来,埃默里大学(Emory University)的评估和认证协会(AAAALAC)对埃默里大学(Emory University)的校园不断认可。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John S. Lollar其他文献
Cryo-EM Structure of Coagulation Factor VIII Bound to a Patient-Derived Anti-A2 Domain Antibody Inhibitor
- DOI:
10.1182/blood-2023-182304 - 发表时间:
2023-11-02 - 期刊:
- 影响因子:
- 作者:
Kenneth C Childers;Jordan Vaughan;John S. Lollar;Christopher B Doering;Carmen Helena Coxon;P. Clint Spiegel - 通讯作者:
P. Clint Spiegel
John S. Lollar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John S. Lollar', 18)}}的其他基金
Unraveling the immune response to factor VIII
揭示对因子 VIII 的免疫反应
- 批准号:
10406900 - 财政年份:2018
- 资助金额:
$ 31.54万 - 项目类别:
The Structural Basis for the Immune Recognition of Factor VIII
因子 VIII 免疫识别的结构基础
- 批准号:
10406902 - 财政年份:2018
- 资助金额:
$ 31.54万 - 项目类别:
Unraveling the immune response to factor VIII
揭示对因子 VIII 的免疫反应
- 批准号:
9522256 - 财政年份:2018
- 资助金额:
$ 31.54万 - 项目类别:
Novel Assays Predicting Phenotypic Heterogeneity in Severe Hemophilia
预测严重血友病表型异质性的新方法
- 批准号:
8464235 - 财政年份:2013
- 资助金额:
$ 31.54万 - 项目类别:
Molecular Heterogeneity in FVIII Inhibitor Patients
FVIII 抑制剂患者的分子异质性
- 批准号:
8464234 - 财政年份:2013
- 资助金额:
$ 31.54万 - 项目类别:
Eradication of FVIII Inhibitors using Gene-Based Therapy
使用基因疗法根除 FVIII 抑制剂
- 批准号:
8391966 - 财政年份:2012
- 资助金额:
$ 31.54万 - 项目类别:
相似国自然基金
基于视频的多模态随机手势认证关键技术研究
- 批准号:62376100
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
电商平台引入绿色认证的经济价值、作用效果及策略优化研究
- 批准号:72301215
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于隐私增强技术的口令安全认证机制研究
- 批准号:62302271
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
车联网环境下基于区块链的跨域认证机制研究
- 批准号:62362013
- 批准年份:2023
- 资助金额:33 万元
- 项目类别:地区科学基金项目
消息认证码设计与分析理论关键问题研究
- 批准号:62372294
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
PATIENT SAFETY MONITORING IN INTERNATIONAL LABORATORIES (SMILE)
国际实验室中的患者安全监测(微笑)
- 批准号:
9915631 - 财政年份:2018
- 资助金额:
$ 31.54万 - 项目类别:
MAINTENANCE OF NIAID SPECIFIC PATHOGEN FREE MACAQUE BREEDING COLONIES
NIAID 无特定病原体猕猴繁殖群的维护
- 批准号:
10705547 - 财政年份:2017
- 资助金额:
$ 31.54万 - 项目类别:
Advancing EFIRM-Liquid Biopsy (eLB) to a CLIA-Certified Laboratory Developed Test (eLB-LDT) for Detection of Actionable EGFR Mutations in NSCLC Patients
将 EFIRM 液体活检 (eLB) 升级为 CLIA 认证的实验室开发测试 (eLB-LDT),用于检测 NSCLC 患者中可操作的 EGFR 突变
- 批准号:
9916842 - 财政年份:2017
- 资助金额:
$ 31.54万 - 项目类别:
PATIENT SAFETY MONITORING IN INTERNATIONAL LABORATORIES (SMILE)
国际实验室中的患者安全监测(微笑)
- 批准号:
8845072 - 财政年份:2012
- 资助金额:
$ 31.54万 - 项目类别:
PATIENT SAFETY MONITORING IN INTERNATIONAL LABORATORIES (SMILE)
国际实验室中的患者安全监测(微笑)
- 批准号:
8750459 - 财政年份:2012
- 资助金额:
$ 31.54万 - 项目类别: